The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: A multicentric study

European Journal of Internal Medicine

Volumn 22, Issue 6, 2011, Pages 587-590

  Fimiani, Basilio ^a   Guardia, Domenico Della ^b   Puoti, Claudio ^c   Adamo, Giuseppe D' ^a   Cioffi, Olimpia ^a   Pagano, Anna ^a   Tagliamonte, Maria Rosaria ^a   Izzi, Antonio ^d  

^a Umberto i Hospital   (Italy)

^b Hospital Santa Maria Della Speranza Battipaglia   (Italy)

^c Marino Hospital Rome   (Italy)

^d AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Albumin; Hepatorenal syndrome; Refractory ascites; Terlipressin

Indexed keywords

ALBUMIN; FUROSEMIDE; SPIRONOLACTONE; TERLIPRESSIN;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; DRUG POTENTIATION; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; MULTICENTER STUDY; PERIPHERAL EDEMA; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; ALBUMINS; ASCITES; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATORENAL SYNDROME; HUMANS; KIDNEY; LIVER CIRRHOSIS; LYPRESSIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 80855147585     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.06.013     Document Type: Article

References (19)

1. European Association for the Study of the Liver EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis J Hepatol 53 2010 397 417
2. B.A. Runyon AASLD Practice Guidelines. Management of adult patients with ascites due to cirrhosis: an update Hepatology 49 2009 2087 2107
3. F. Salerno, M. Guevara, M. Bernardi, R. Moreau, F. Wong, and P. Angeli Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis Liver Int 30 2010 937 947
4. A. Gatta, M. Bolognesi, and C. Merkel Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis Mol Aspects Med 29 2008 119 129 (Pubitemid 351312222)
5. A. Albillos, R. Bañares, M. Gonzáles, M.V. Catalina, and L.M. Molinero A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites J Hepatol 43 2005 990 996 (Pubitemid 41627984)
6. P. Angeli, S. Fasolato, E. Mazza, L. Okolicsanyi, G. Maresio, and E. Velo Combined versus sequential diuretic treatment of ascites in nonazotemic patients with cirrhosis: results of an open randomized clinical trial Gut 59 2010 98 104
7. R. Moreau, and D. Lebrec The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond Hepatology 43 2006 385 394
8. P.G. Velamati, and H.F. Herlong Treatment of refractory ascites Curr Treat Options Gastroenterol 9 2006 530 537 (Pubitemid 44803674)
9. K.P. Moore, F. Wong, P. Gines, M. Bernardi, A. Ochs, and F. Salerno The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club Hepatology 38 2003 258 266 (Pubitemid 36775818)
10. A.A. Magan, A.A. Khalil, and M.H. Ahmed Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists Word J Gastroenterol 16 2010 5139 5147
11. L. Spahr, J.P. Villeneuve, H.K. Tran, and G. Pomier-Layrargues Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites Hepatology 33 2001 28 31 (Pubitemid 32016884)
12. B.E. Senousy, and P.V. Draganov Evaluation and management of patients with refractory ascites World J Gastroenterol 15 2009 67 80
13. R. de Franchis Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 53 2010 762 768
14. F.H. Saner, A. Canbay, G. Gerken, and C.E. Broelsch Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome Expert Rev Gastroenterol Hepatol 1 2007 207 217
15. A. Krag, S. Møller, J.H. Henriksen, N.H. Holstein-Rathlou, F.S. Larsen, and F. Bendtsen Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome Hepatology 46 2007 1863 1871
16. L.L. Gluud, K. Christensen, E. Christensen, and A. Krag Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome Hepatology 51 2009 576 584
17. A. Gadano, R. Moreau, F. Vachiery, T. Soupison, S. Yang, and S. Cailmail Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites J Hepatol 26 1997 1229 1234 (Pubitemid 27346634)
18. A. McGibbon, G.I. Chen, K.M. Peltekian, and S.V. van Zanten An evidence-based manual for abdominal paracentesis Dig Dis Sci 52 2007 3307 3315 (Pubitemid 350077196)
19. J.J. Kuiper, H.R. van Buuren, and R.A. de Man Ascites in cirrhosis: a review of management and complications Neth J Med 65 2007 283 288 (Pubitemid 47520930)